PB2334: CENTRAL NERVOUS SYSTEM (CNS) RELAPSE IN DIFFUSE LARGE B-CELL LYMPHOMA: CNS-SAMATYA RISK MODEL

PB2334: CENTRAL NERVOUS SYSTEM (CNS) RELAPSE IN DIFFUSE LARGE B-CELL LYMPHOMA: CNS-SAMATYA RISK MODEL

Bibliographic Details
Main Authors:	Osman Yokus, Mediha Irem Onar, Istemi Serin
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000976056.48193.1f

Similar Items

PB1752: SAMATYA-PREDICTING SCORE IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL): COMBINING CLINICAL FEATURES WITH FLOW CYTOMETRY
by: Tahir Alper Cinli, et al.
Published: (2023-08-01)

A new approach in acute myeloid leukemia (AML): Samatya-predicting score
by: Istemi Serin, et al.
Published: (2022-01-01)

PB1841: A NEW APPROACH IN ACUTE MYELOID LEUKEMIA (AML): SAMATYA-PREDICTING SCORE
by: I. Serin, et al.
Published: (2022-06-01)

Multiply Relapsed Secondary CNS Non-Germinal Center Diffuse Large B-Cell Lymphoma Successfully Treated with CNS-Centric Therapy
by: Fournier LL, et al.
Published: (2023-08-01)

Low Incidence of Central Nervous System (CNS) Relapse of Diffuse Large B-Cell Lymphoma despite Limited Use of Intrathecal Prophylaxis
by: Aamer Aleem, et al.
Published: (2022-10-01)

Recurrence of lymphoma with isolated pericardial mass: a case report
by: Istemi Serin, et al.
Published: (2020-10-01)

Systemic Relapse in a Young Adult Patient with Primary CNS Diffuse Large B-Cell Lymphoma
by: Adam Khorasanchi, et al.
Published: (2022-01-01)

High-dose methotrexate is effective for prevention of isolated CNS relapse in diffuse large B cell lymphoma
by: Shin Yeu Ong, et al.
Published: (2021-08-01)

PB2400: THE EFFECT OF BONE MARROW CD4/CD8+ RATIO ON RESPONSE TO TREATMENT AND SURVIVAL IN LYMPHOMAS
by: Vahit Can Cavdar, et al.
Published: (2023-08-01)

Real-world experiences of CNS-directed chemotherapy followed by autologous stem cell transplantation for secondary CNS involvement in relapsed or refractory diffuse large B-cell lymphoma
by: Sun Young Jeong, et al.
Published: (2023-01-01)

Lenalidomide and temozolomide combination in a very elderly patient with CNS relapse of diffuse large b-cell lymphoma.
by: Emanuele Cencini, et al.
Published: (2017-06-01)

Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse
by: Sabela Bobillo, et al.
Published: (2021-06-01)

Primary central nervous system (CNS) lymphoma in immunocompetent patients.
by: Plasswilm, L, et al.
Published: (2002)

Phase II study of central nervous system (CNS)-directed chemotherapy including high-dose chemotherapy with autologous stem cell transplantation for CNS relapse of aggressive lymphomas
by: Agnieszka Korfel, et al.
Published: (2013-03-01)

Primary CNS lymphoma.
by: Losseff, N, et al.
Published: (1993)

CNS Genes Implicated in Relapse
by: Willard M. Freeman, et al.
Published: (2008-01-01)

CNS Genes Implicated in Relapse
by: Kara L. Kuntz-Melcavage, et al.
Published: (2008-01-01)

PB2321: THE EFFECT OF PRE-TREATMENT SERUM KINDLIN-3 ON HODGKIN AND NON-HODGKIN LYMPHOMAS: A SINGLE CENTER EXPERIENCE
by: Melike Keskin, et al.
Published: (2023-08-01)

Future Perspective for ALK-Positive Anaplastic Large Cell Lymphoma with Initial Central Nervous System (CNS) Involvement: Could Next-Generation ALK Inhibitors Replace Brain Radiotherapy for the Prevention of Further CNS Relapse?
by: Makito Tanaka, et al.
Published: (2023-05-01)

Cranial Radiation Therapy as Salvage in the Treatment of Relapsed Primary CNS Lymphoma
by: Matthew E. Volpini, et al.
Published: (2022-10-01)

Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden
by: Sara Harrysson, et al.
Published: (2021-01-01)

Primary diffuse large B-cell lymphoma of the CNS, with a “Lymphomatosis cerebri” pattern
by: Balamurugan Thirunavukkarasu, et al.
Published: (2021-04-01)

PB2234: EFFECT OF HYDROXYUREA ON INFLAMMATORY MARKERS IN PATIENTS WITH BCR-ABL NEGATIVE MYELOPROLIFERATIVE DISEASES
by: Oguz Altunok, et al.
Published: (2023-08-01)

Review: Primary CNS lymphoma
by: Uwe Schlegel
Published: (2009-03-01)

A Small Case Series of Intravascular Large B-Cell Lymphoma with Unexpected Findings: Subset of Cases with Concomitant Extravascular Central Nervous System (CNS) Involvement Mimicking Primary CNS Lymphoma
by: Kate Poropatich, et al.
Published: (2017-05-01)

PB2308: NIVOLUMAB-BASED THERAPY OF RELAPSED OR REFRACTORY PRIMARY LARGE B-CELL LYMPHOMA OF IMMUNE-PRIVILEGED SITES AND DLBCL WITH SECONDARY CNS INVOLVEMENT
by: Andrey Gavrilenko, et al.
Published: (2023-08-01)

PB2245: POLYCYTHEMIA VERA (PV) AND SECONDARY POLYCYTHEMIA (SP): ARE METABOLIC DIFFERENCES JUST THEORIES?
by: Osman Yokus, et al.
Published: (2023-08-01)

Diffusion-Weighted MRI Reflects Proliferative Activity in Primary CNS Lymphoma.
by: Stefan Schob, et al.
Published: (2016-01-01)

PB2096: A PHASE 1B/2 STUDY OF GB5121, A NOVEL, HIGHLY SELECTIVE, POTENT, AND CNS-PENETRANT BTK INHIBITOR FOR RELAPSED/REFRACTORY PRIMARY/SECONDARY CNS LYMPHOMA AND PRIMARY VITREORETINAL LYMPHOMA
by: C. Soussain, et al.
Published: (2022-06-01)

Beyond the Blood:Brain Barrier: The Importance of Central Nervous System (CNS) Pharmacokinetics for the Treatment of CNS Tumors, Including Diffuse Intrinsic Pontine Glioma
by: Katherine Elizabeth Warren
Published: (2018-07-01)

Primary CNS lymphoma: Diagnosis and treatment
by: Herrlinger, U, et al.
Published: (2003)

Primary CNS Lymphoma in Seropositive Child
by: S. T. Bandichhode, et al.
Published: (2013-01-01)

Primary CNS lymphoma masquerading as ventriculitis
by: Shalesh Rohatgi, et al.
Published: (2022-01-01)

Characteristics of Central Nervous System (CNS) Involvement in Children With Non-Hodgkin’s Lymphoma (NHL) and the Diagnostic Value of CSF Flow Cytometry in CNS Positive Disease
by: Shuang Huang, et al.
Published: (2021-05-01)

Case Report: Diffuse cerebral lymphomatosis with superimposed multifocal primary CNS lymphoma
by: Elizabeth Huai-Feng Li, et al.
Published: (2024-11-01)

Isolated Central Nervous System (CNS) Relapse in Paediatric Acute Promyelocytic Leukaemia: A Systematic Review
by: Smeeta Gajendra, et al.
Published: (2017-03-01)

Central Nervous System (CNS) T-Cell Lymphoma as the Presenting Manifestation of Late-Onset Combined Immunodeficiency
by: Anthony Jeffrey, et al.
Published: (2023-01-01)

Phase 1 investigation of lenalidomide/rituximab plus outcomes of lenalidomide maintenance in relapsed CNS lymphoma
by: James L. Rubenstein, et al.
Published: (2018-07-01)

Nanomedicine strategies for central nervous system (CNS) diseases
by: Shreya Nagri, et al.
Published: (2023-08-01)

PB2106: REDUCTION OF METHOTREXATE (MTX) LEVELS AFTER GLUCARPIDASE IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) AT RISK OF CENTRAL NERVOUS SYSTEM (CNS) INVOLVEMENT WHO RECEIVE HDMTX: PHASE 2
by: A. De La Fuente, et al.
Published: (2022-06-01)